7.2.15.6.10DALearning Outcome
Setting up acute / chronic pain service Non-technical skills All general NTS (See Background). Knowledge
lines 1907–1917id: LO_7.2.15.6_10_DA
52 items
- 7.2.15.6_10.1DADiagnosis and aetiology of peri-operative liver dysfunction
- 7.2.15.6_10.2DAAnaesthetic drug associated hepatitis
- 7.2.15.6_10.3DAAcute hepatitis – causes and physiological/pharmacological implications
- 7.2.15.6_10.4DAPathophysiology of acute and chronic alcohol abuse
- 7.2.15.6_10.5DAPre-cirrhotic conditions e.g. non-alcoholic fatty liver disease (NAFLD)
- 7.2.15.6_10.6DACirrhosis and end-stage liver disease – aetiologies; classification of severity for transplant and non-transplant surgery; physiological impact and multi-organ dysfunction (cardiac, pulmonary, renal)
- 7.2.15.6_10.7DARisk and severity assessment in cirrhotic patients – Child’s Pugh classification and MELD score
- 7.2.15.6_10.8DACoagulation status
- 7.2.15.6_10.9DADegree and potential implications of portal hypertension
- 7.2.15.6_10.10DAAssessment of severity and microbiology of biliary sepsis
- 7.2.15.6_10.11DAAdequacy of control of secretory tumour effects
- 7.2.15.6_10.12DANutritional status
- 7.2.15.6_10.13DAMetabolic derangements
- 7.2.15.6_10.14DACoagulopathy
- 7.2.15.6_10.15DASepsis
- 7.2.15.6_10.16DAAnaemia - patient blood management (PBM) principles
- 7.2.15.6_10.17DACirrhotic CVS disease including cardiomyopathy and pulmonary hypertension
- 7.2.15.6_10.18DAHepatopulmonary Syndrome, Pleural effusions
- 7.2.15.6_10.19DAHepato-renal dysfunction
- 7.2.15.6_10.20DAClinical assessment, diagnosis, investigation, management, monitoring and care of patients with HPB disorders undergoing HPB surgery, including:
- 7.2.15.6_10.21DADiabetes Mellitus
- 7.2.15.6_10.22DAPancreatic malabsorption
- 7.2.15.6_10.23DAInsulinoma
- 7.2.15.6_10.24DASevere acute pancreatitis
- 7.2.15.6_10.25DAMalignancies (resectable and irresectable); may be associated with nutritional disorders
- 7.2.15.6_10.26DAGastro-oesophageal reflux
- 7.2.15.6_10.27DAMotility disorder (achalasia and systemic sclerosis)
- 7.2.15.6_10.28DAHaemorrhage
- 7.2.15.6_10.29DAGastric ulceration
- 7.2.15.6_10.30DAGastro-oesophageal reflux
- 7.2.15.6_10.31DABariatric surgery including chemotherapeutic agents.
- 7.2.15.6_10.32DAClinical features
- 7.2.15.6_10.33DAAnaesthetic considerations
- 7.2.15.6_10.34DAPerioperative management
- 7.2.15.6_10.35DAEnsuring post-operative ICU facilities are available and communicating with intensivists.
- 7.2.15.6_10.36DALaboratory/blood bank notified and in possession of samples to hasten response in the event of major bleeding
- 7.2.15.6_10.37DAAccess to infusion devices and Vaso-active agents
- 7.2.15.6_10.38DAAccess to cell salvage
- 7.2.15.6_10.39DARemain in contact with surgeon, intensivist, patient and family
- 7.2.15.6_10.40DAGuide provision of analgesia
- 7.2.15.6_10.41DAAttend MDT meetings / obtain information regarding patient care pathway
- 7.2.15.6_10.42DAAttend meetings to remain up to date on state of the art approaches
- 7.2.15.6_10.43DADiscuss the proposed patient care pathway with surgeon to acquire situational awareness
- 7.2.15.6_10.44DACommunicate care pathways with patients / family and post-operative care teams
- 7.2.15.6_10.45DAOf resource limitations such as inadequate/ lack equipment, lack of medications and postoperative care (e.g. High Care and Intensive Care Units beds) required for high risk/ general surgery.
- 7.2.15.6_10.46DAOf potential complications for specific endocrine conditions or intra-operative complications that may require a sudden change in course of procedure.
- 7.2.15.6_10.47DAActivation of major bleeding team / response / protocol early in the context of surgical haemorrhage
- 7.2.15.6_10.48DARequesting help from experienced colleagues when dealing with endocrine disorders one is unfamiliar with.
- 7.2.15.6_10.49DACollaborate with other clinicians and experts and nurses when managing endocrine disorders or complicated patients with multiple endocrine or HPB pathologies.
- 7.2.15.6_10.50DABe aware of the importance of managing patient expectations with respect to perioperative outcomes and recovery for high-risk patients or for high- risk/general surgery.
- 7.2.15.6_10.51DAAppropriate patient counselling and disclosures and accurate and effective information transfer to post-operative ICU and pain teams.
- 7.2.15.6_10.52DACommunication with next-of-kin (having received patient consent pre- operatively). Awareness of security of electronic communications. Pre-, intra- and post-op communication about the clinical situation, e.g. resectability of malignant lesions